The antibacterial hemostatic gels market is estimated to secure a valuation of US$ 1.4 Billion in 2023 and is estimated to rise to US$ 2.6 billion by 2033. The market is anticipated at a CAGR of 6.4% during the forecast period. The factors accelerating the demand for antibacterial hemostatic gels are as follows-
The antibacterial hemostatic gels are used to stop the bleeding or hemorrhage caused by wounds or surgical processes. These gels have antibacterial properties which stop the growth of bacteria near the gel. The antibacterial hemostatic gel market is expected to witness lucrative growth owing to the increased demand for hemostatic gels during surgical procedures.
Another factor likely to drive the market growth includes the growing geriatric population which is prone to chronic diseases and injuries. Also, the increased cases of routine injuries and wounds among the population and the high risk of infections associated with wounds, are expected to boost the sales of antibacterial hemostatic gels throughout the forecast period.
The North American antimicrobial hemostatic gels market is expected to account for the largest revenue share during the forecast period owing to the increased number of surgeries performed in the region. Additionally, the availability of a wide range of hemostatic gel products in the region is supporting the market growth during the forecast period.
On the other hand, the antibacterial hemostatic gels market in Europe is witnessing significant growth in recent years. Several companies in Europe are providing innovative products to meet the growing demand. Asia Pacific’s antibacterial hemostatic gels market is projected to grow in near future owing to the developing healthcare sector and increased demand for innovative products in the healthcare industry. Also, the growing demand for hemostats owing to the increased number of surgeries performed in the region drives the market growth in the region.
Some of the leading players operating in the antibacterial haemostatic gels market are Medcura, Zoetis Inc, and IDEXX Laboratories Inc, among others. The market players are focusing on strategic activities to increase their market share.
The major players in the antibacterial hemostatic gel market are using different strategies like acquisitions, mergers, and partnerships to increase their brand presence. Some of the developments from the market are listed below.
For instance in December 2022- Medcura Inc announced that Walmart will be selling the company’s antibacterial wound gel Rapid Seal through Wlamart.com The rapid seal is the bleeding management and antibacterial barrier that help to reduce infection.
The antibacterial haemostatic gels market is expected to grow in the coming years. The increasing demand for effective antibacterial haemostatic gel products for providing better wound care during surgical procedures is expected to drive market growth during the forecast period. Also, the increased application of antibacterial haemostatic gels in hospitals, home care, diagnostic centers, and clinics increases the sales of the market. Several start-ups have entered the antibacterial hemostatic gels market with innovative products with the use of new technology.
For instance, founded in 2013- Gel-e-life sciences is the provider of a wound care platform for hemostasis company, the company develops hemostasis products for surgical, medical, and consumer applications. These products are made using natural, and biocompatible polymers.
| Data Point | Key statistics |
|---|---|
| Expected Market Value in 2023 | US$ 1.4 Billion |
| Projected Market Value in 2033 | US$ 2.6 Billion |
| Growth Rate (2023 to 2033) | CAGR of 6.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to the latest research by Future Market Insights, antibacterial haemostatic gels Market is set to experience xxx% growth during the year 2021-2031. The growth of veterinary home diagnostics is anticipated due to rise in demand of controlling minor bleedings along with seal cut and scrapes.
Antibacterial haemostatic gels adhere the wound and create a seal around it. According to the research, antibacterial haemostatic gels consist of antibacterial properties that help in preventing the growth of bacteria within the gel.
Wound infections along with uncontrollable bleeding acts as primary challenge for emergency surgical activities, which includes deep and non-compressible bleeding in the hospital or clinic or on the battleground.
For controlling haemorrhaging on the spot from non-compressible wounds, double network hydrogels based on 3,4-dihyoxyphenylalanine cation copolymer were innovated for wound healing. This advantage offered by Antibacterial haemostatic gels drives the market growth at a significant pace.
Moreover, growing demand for antibacterial properties for wound healing immediately is also uplifting the demand for Antibacterial haemostatic gels sales in the market.
Principal Consultant
Antibacterial haemostatic gels provide better tissue adhesion strength as compared to other commercially available gels in the market. They also provide with the enhanced haemostatic capability and higher performance rate.
These adhesive antibacterial haemostatic gels with better biocompatibility, fast gelling, antibacterial activity and also rapid haemostasis offers enhanced applications in wound healing. Thus, rise in demand for haemostatic gels for improved and faster wound healing is expected to boost the demand for Antibacterial haemostatic gels market.
USA. and Canada are expected to have the highest share and therefore will dominate the antibacterial haemostatic gels Market. This is due to large amount is spent on the treatment of various complex and primary wounds in this region. Various technological advancements and growth in income rate of the individuals is also driving the market growth in this region.
For instance, In July 2021, Medcura Inc a medical device company announced a new launching of high performance antibacterial haemostatic gel known as rapid gel.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The European market for veterinary home diagnostics is estimated to grow at a considerable rate during the forecast period. This surge in growth is due to the growing expenditure on surgical procedures Moreover, the high risk of infections due to major and minor wounds is also expected to drive the sales of Antibacterial haemostatic gels market.
According to Hospimedica daily clinical news, suggests that hydrogel dressing is much beneficial as they offer antibacterial, responsive, biodegradable and injectable properties for faster and better healing.
Some of the key player operating in the antibacterial haemostatic gels Market is Medura. Manufacturers in the market focus on carrying out certain strategic activities such as acquisitions and merger, expansion, product launch, etc. For instance, in May 2020, Zoetis Inc. announced the acquisition of Abaxis in a deal of US$ 1.9 Bn.
In June 2021, IDEXX laboratories inc. announced the acquisition of ezyVet in cloud software expansion push. The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Explore Healthcare Insights
View Reports
Antibacterial Haemostatic Gels Market
